The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Beta-Nicotinamide Mononucleotide (NMN) Market Research Report 2025
Synopsis
Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
The global Beta-Nicotinamide Mononucleotide (NMN) market was valued at US$ 297.5 million in 2023 and is anticipated to reach US$ 707.1 million by 2030, witnessing a CAGR of 12.6% during the forecast period 2024-2030.
Global key players of beta-nicotinamide mononucleotide (NMN) include GeneHarbor, Mirailab Bioscience, EffePharm, Herbalmax and Genex Formulas. Asia-Pacific is the largest producer, holds a share over 60%, followed by North America and Europe. In terms of product type, content greater than or equal to 98% is the largest segment, with a share over 99%. And in terms of application, the largest segment is Health Care Products, with a share over 99%.
This report aims to provide a comprehensive presentation of the global market for Beta-Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Nicotinamide Mononucleotide (NMN).
Report Scope
The Beta-Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Beta-Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Beta-Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Segment by Type
Content Greater than or Equal to 98%
Content Less than 98%
Segment by Application
Health Care Products
Cosmetics
Others
Production by Region
North America
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Beta-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Beta-Nicotinamide Mononucleotide (NMN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Beta-Nicotinamide Mononucleotide (NMN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
The global Beta-Nicotinamide Mononucleotide (NMN) market was valued at US$ 297.5 million in 2023 and is anticipated to reach US$ 707.1 million by 2030, witnessing a CAGR of 12.6% during the forecast period 2024-2030.
Global key players of beta-nicotinamide mononucleotide (NMN) include GeneHarbor, Mirailab Bioscience, EffePharm, Herbalmax and Genex Formulas. Asia-Pacific is the largest producer, holds a share over 60%, followed by North America and Europe. In terms of product type, content greater than or equal to 98% is the largest segment, with a share over 99%. And in terms of application, the largest segment is Health Care Products, with a share over 99%.
This report aims to provide a comprehensive presentation of the global market for Beta-Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Beta-Nicotinamide Mononucleotide (NMN).
Report Scope
The Beta-Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Beta-Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Beta-Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Segment by Type
Content Greater than or Equal to 98%
Content Less than 98%
Segment by Application
Health Care Products
Cosmetics
Others
Production by Region
North America
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Beta-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Beta-Nicotinamide Mononucleotide (NMN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Beta-Nicotinamide Mononucleotide (NMN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Beta-Nicotinamide Mononucleotide (NMN) Market Overview
1.1 Product Definition
1.2 Beta-Nicotinamide Mononucleotide (NMN) Segment by Type
1.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Content Greater than or Equal to 98%
1.2.3 Content Less than 98%
1.3 Beta-Nicotinamide Mononucleotide (NMN) Segment by Application
1.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2019-2030)
1.4.4 Global Beta-Nicotinamide Mononucleotide (NMN) Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers (2019-2024)
2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Beta-Nicotinamide Mononucleotide (NMN), Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Beta-Nicotinamide Mononucleotide (NMN) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Product Offered and Application
2.8 Global Key Manufacturers of Beta-Nicotinamide Mononucleotide (NMN), Date of Enter into This Industry
2.9 Beta-Nicotinamide Mononucleotide (NMN) Market Competitive Situation and Trends
2.9.1 Beta-Nicotinamide Mononucleotide (NMN) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Beta-Nicotinamide Mononucleotide (NMN) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Beta-Nicotinamide Mononucleotide (NMN) Production by Region
3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Region (2019-2030)
3.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Beta-Nicotinamide Mononucleotide (NMN) by Region (2025-2030)
3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Region (2019-2030)
3.4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Beta-Nicotinamide Mononucleotide (NMN) by Region (2025-2030)
3.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2019-2024)
3.6 Global Beta-Nicotinamide Mononucleotide (NMN) Production and Value, Year-over-Year Growth
3.6.1 North America Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2019-2030)
3.6.2 China Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2019-2030)
3.6.3 Japan Beta-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2019-2030)
4 Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region
4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2019-2030)
4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2019-2024)
4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2019-2030)
5.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2019-2024)
5.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Type (2025-2030)
5.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2019-2030)
5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2019-2030)
5.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2019-2024)
5.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Type (2025-2030)
5.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2019-2030)
5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Type (2019-2030)
6 Segment by Application
6.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2019-2030)
6.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2019-2024)
6.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production by Application (2025-2030)
6.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2019-2030)
6.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2019-2030)
6.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2019-2024)
6.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value by Application (2025-2030)
6.2.3 Global Beta-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2019-2030)
6.3 Global Beta-Nicotinamide Mononucleotide (NMN) Price by Application (2019-2030)
7 Key Companies Profiled
7.1 GeneHarbor
7.1.1 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.1.2 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
7.1.4 GeneHarbor Main Business and Markets Served
7.1.5 GeneHarbor Recent Developments/Updates
7.2 Herbalmax
7.2.1 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.2.2 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Herbalmax Main Business and Markets Served
7.2.5 Herbalmax Recent Developments/Updates
7.3 Genex Formulas
7.3.1 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.3.2 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Genex Formulas Main Business and Markets Served
7.3.5 Genex Formulas Recent Developments/Updates
7.4 Shinkowa Pharmaceutical
7.4.1 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.4.2 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Shinkowa Pharmaceutical Main Business and Markets Served
7.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
7.5 Maac10 Formulas
7.5.1 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.5.2 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Maac10 Formulas Main Business and Markets Served
7.5.5 Maac10 Formulas Recent Developments/Updates
7.6 EffePharm
7.6.1 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.6.2 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
7.6.4 EffePharm Main Business and Markets Served
7.6.5 EffePharm Recent Developments/Updates
7.7 Bontac
7.7.1 Bontac Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.7.2 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Bontac Main Business and Markets Served
7.7.5 Bontac Recent Developments/Updates
7.8 CELFULL
7.8.1 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.8.2 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
7.8.4 CELFULL Main Business and Markets Served
7.7.5 CELFULL Recent Developments/Updates
7.9 Kingdomway
7.9.1 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Corporation Information
7.9.2 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Portfolio
7.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Kingdomway Main Business and Markets Served
7.9.5 Kingdomway Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Chain Analysis
8.2 Beta-Nicotinamide Mononucleotide (NMN) Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Beta-Nicotinamide Mononucleotide (NMN) Production Mode & Process
8.4 Beta-Nicotinamide Mononucleotide (NMN) Sales and Marketing
8.4.1 Beta-Nicotinamide Mononucleotide (NMN) Sales Channels
8.4.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors
8.5 Beta-Nicotinamide Mononucleotide (NMN) Customers
9 Beta-Nicotinamide Mononucleotide (NMN) Market Dynamics
9.1 Beta-Nicotinamide Mononucleotide (NMN) Industry Trends
9.2 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers
9.3 Beta-Nicotinamide Mononucleotide (NMN) Market Challenges
9.4 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
